Virtu KCG Holdings’s Bio-Rad Laboratories Class A BIO Stock Holding History

Virtu KCG Holdings’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$389K	Sell	1,718 -541	-24%	-$118K	0.01%	1377
2017 Q1	$450K	Buy	+2,259	New	+$435K	0.01%	1492
2016 Q3	–	Sell	-1,466	Closed	-$210K	–	3073
2016 Q2	$210K	Sell	1,466 -820	-36%	-$117K	﹤0.01%	2273
2016 Q1	$313K	Sell	2,286 -399	-15%	-$52.4K	0.01%	1651
2015 Q4	$372K	Sell	2,685 -3,420	-56%	-$474K	0.01%	1899
2015 Q3	$820K	Buy	+6,105	New	+$879K	0.01%	1052
2015 Q2	–	Sell	-2,478	Closed	-$335K	–	3327
2015 Q1	$335K	Buy	2,478 +519	+26%	+$64.3K	0.01%	1792
2014 Q4	$236K	Buy	+1,959	New	+$225K	﹤0.01%	2668
2014 Q3	–	Sell	-2,034	Closed	-$243K	–	3587
2014 Q2	$243K	Buy	+2,034	New	+$248K	﹤0.01%	2817

Other funds holding BIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Virtu KCG Holdings's BIO Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Bio-Rad Laboratories Class A (BIO) stake by 24% in Q2 2017, selling an estimated $118K and leaving 1,718 shares worth $389K. The position accounts for 0.01% of the portfolio, ranked #1377.

Virtu KCG Holdings first reported a position in BIO in Q2 2014 and has held it in 9 quarters since. The position peaked at $820K in Q3 2015. 276 funds tracked by Wall St. Rank hold BIO as of Q2 2017.

Virtu KCG Holdings held 1,718 shares of Bio-Rad Laboratories Class A worth $389K as of Q2 2017.
Virtu KCG Holdings sold 541 Bio-Rad Laboratories Class A shares in Q2 2017, an estimated $118K.
Bio-Rad Laboratories Class A made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1377 holding.
Virtu KCG Holdings first reported a position in Bio-Rad Laboratories Class A in Q2 2014 and has held it in 9 quarters since.
Virtu KCG Holdings's Bio-Rad Laboratories Class A position peaked at $820K in Q3 2015.
276 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.